clinical trial · NCT01347255
A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris
LEO Pharma·phase2·completed·n = 24
Psoriasis VulgarisLEO90100 cutaneous spray, ointmentLEO 90100 cutaneous spray, ointment, vehicle with betamethasone dipropionateLEO 90100 cutaneous spray, ointment, vehicleDaivobet® ointment
brief summary
The purpose of the study is to evaluate the anti-psoriatic effect of LEO 90100 cutaneous spray ointment, using the psoriasis plaque test modified from the method developed by KJ Dumas and JR Scholtz.
started
May 1, 2011
primary completion
Jun 1, 2011
completion
Jun 1, 2011
last updated
Mar 7, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol